Tvardi Therapeutics, Inc.
For the period ended Apr 1, 2025. Filed Apr 1, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Apr 1, 2025 · Filed Apr 1, 2025
Use the contents to explore the available documents and sections.
TVRD$0.96+10.8%Stored close · as of Nov 6, 2026
Contents
EX-99.3 · Pro forma notes:
Pro forma notes:
6(A) Derived from the audited consolidated balance sheet of Cara as of December 31, 2024
6(B) Derived from the audited balance sheet of Tvardi as of December 31, 2024
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.